InMed is developing this biosynthesis process for the potential manufacturing of up to 90+ naturally-occurring cannabinoids to treat various diseases.
InMed Pharmaceuticals Inc.
4 records totalling $760,671.00 CAD, from official Government of Canada open data.
Embed this chart
By department
| National Research Council Canada | $760,671 | 4 records |
Records
InMed Pharmaceuticals Inc.
$500,000.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
FY 2018-2019
Canada
InMed Pharmaceuticals Inc.
$109,584.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Innovation Assistance Program
FY 2020-2021
Canada
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
InMed Pharmaceuticals Inc.
$91,476.00
National Research Council Canada | Conseil national de recherches Canada
Innovation Assistance Program
FY 2020-2021
Canada
The funding provided from the IAP program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
InMed Pharmaceuticals Inc.
$59,611.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Innovation Assistance Program
FY 2020-2021
Canada
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.